An experimental single-dose, intranasal influenza vaccine candidate, was found safe and produced a durable immune response when tested in a Phase 1 study, announced the National Institutes of Health.
This study was sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) and published in the Journal of Clinical Investigation on February 2, 2021.
Intranasal Flu Shot Candidate Spurs Strong Immune Response
Intranasal Flu Shot Candidate Spurs Strong Immune Response
An experimental single-dose, intranasal influenza vaccine candidate, was found safe and produced a durable immune response when tested in a Phase 1 study, announced the National Institutes of Health.
This study was sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) and published in the Journal of Clinical Investigation on February 2, 2021.
COVAX Publishes First Interim COVID-19 Vaccine Distribution Forecast
The Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance, and the World Health Organisation (WHO), as co-leads of the COVAX initiative for equitable global access to COVID-19 vaccines, published COVAX’s first interim COVID-19 vaccine distribution forecast.
About Four in 10 U.S. Adults Skipped Medical Care During Pandemic
Some cited fear of COVID-19 and financial reasons
Many Cancer Survivors Have Conditions Linked to Risk for Severe COVID-19 Illness
56.4 percent of cancer survivors report having one or more conditions, with increased prevalence in Black survivors
Biden Administration to Start Shipping COVID-19 Vaccines Directly to U.S. Pharmacies
In addition, starting this week, states are receiving 5 percent more vaccine doses
COVID-19 Vaccine Uptake Moderately High for Residents at SNFs
Median of 77.8 percent of residents and 37.5 percent of staff members per facility received one or more doses of COVID-19 vaccine
AstraZeneca Vaccine Guards Against Severe COVID-19 Illness
Researchers also found that a single dose of the vaccine was 76 percent effective at preventing COVID-19
WHO Team Probing COVID-19 Origins Visits Wuhan Research Center
WHO team has visited hospitals, research institutes, and a traditional wet market linked to many of the first cases